Reversal of coagulopathy in Kasabach‐Merritt syndrome with tranexamic acid
A.J. Bell, Morag Chisholm, M. C. Hickton
Abstract
A.J. Bell, Morag Chisholm, M. C. Hickton
Abstract
An infant with a giant cavernous haemangioma developed a severe consumption coagulopathy and systemic bleeding. Replacement therapy with cryoprecipitate produced only a transient improvement in the abnormal clotting, but the addition of tranexamic acid resulted in sustained correction, permitting corrective surgery to be performed.
OpenAlex reports 24 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
An infant with a giant cavernous haemangioma developed a severe consumption coagulopathy and systemic bleeding. Replacement therapy with cryoprecipitate produced only a transient improvement in the abnormal clotting, but the addition of tranexamic acid resulted in sustained correction, permitting corrective surgery to be performed.
Key concepts: Tranexamic acid, Cryoprecipitate, Kasabach–Merritt syndrome, Coagulopathy, Medicine, Surgery, Disseminated intravascular coagulation, Anesthesia